Company Profile

BullFrog AI harnesses artificial intelligence and machine learning to advance pharmaceutical R&D and drug target discovery, providing AI-accelerated outputs that are optimized and human-validated. 

BullFrog AI operates through three complementary capabilities, deployable independently or as a combined platform: bfPREP™ for biology-aware data harmonization, bfLEAP® for causal AI analytics and patient subgroup discovery, and bfARENAS™ for structured, auditable decision support. The common thread across all three: every output is traceable, every analytical decision is logged, and every recommendation is designed to be reviewed and validated by the scientific team before it drives a decision.

Our mission is to improve lives by identifying critical connections between therapies and highly responsive patients – in less time, with less cost, and more precision.

Industry Classifications

Sector:
Artificial Intelligence

Industry:
Biotechnology

NAICS:
Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC:
Computer Processing and Data Preparation and Processing Services (7374)

Contact Information

Investor Relations
Erika Schultz
Director & Head of Investor Relations and
Corporate Communications
ir@bullfrogai.com

Company Contact
BullFrog AI Holdings, Inc.
325 Ellington Blvd.
#317
Gaithersburg, MD 20878
T: 240-658-6710
info@bullfrogai.com